Denali Therapeutics (DNLI)'s 30-day implied volatility (IV30) was 46.6% at the close on October 30, 2026, down from 52.6% the day before, against a 52-week range of 35.9% to 117.6%. Its 20-day historical volatility was 44.3%.
Data as of October 30, 2026.